Education
About Us
Working with TipRanks
Follow Us
Bioextrax AB (DE:85X0)
FRANKFURT:85X0
85X0 Stock Chart & Stats
Day’s Range― - ―
52-Week Range€0.18 - €0.34
Previous CloseN/A
Volume0.00
Average Volume (3M)0.00
Market Cap
€12.00M
Enterprise Value€113.72M
Total Cash (Recent Filing)€17.27M
Total Debt (Recent Filing)€0.00
Price to Earnings (P/E)―
Beta0.77
Next Earnings
Nov 21, 2025EPS Estimate
>-0.01Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding39,729,134
10 Day Avg. Volume0
30 Day Avg. Volume0
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
85X0 FAQ
What was Bioextrax AB’s price range in the past 12 months?
Bioextrax AB lowest stock price was €0.18 and its highest was €0.34 in the past 12 months.
What is Bioextrax AB’s market cap?
Bioextrax AB’s market cap is €12.00M.
When is Bioextrax AB’s upcoming earnings report date?
Bioextrax AB’s upcoming earnings report date is Nov 21, 2025 which is in 82 days.
How were Bioextrax AB’s earnings last quarter?
Bioextrax AB released its earnings results on Aug 21, 2025. The company reported -€0.01 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.01.
Is Bioextrax AB overvalued?
According to Wall Street analysts Bioextrax AB’s price is currently Overvalued.
Does Bioextrax AB pay dividends?
Bioextrax AB does not currently pay dividends.
What is Bioextrax AB’s EPS estimate?
Bioextrax AB’s EPS estimate is >-0.01.
How many shares outstanding does Bioextrax AB have?
Bioextrax AB has 39,729,134 shares outstanding.
What happened to Bioextrax AB’s price movement after its last earnings report?
Bioextrax AB reported an EPS of -€0.01 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -6.667%.
Which hedge fund is a major shareholder of Bioextrax AB?
Currently, no hedge funds are holding shares in DE:85X0
Company Description
Bioextrax AB
Bioextrax AB (publ) develops and commercializes a bio-based extraction platform technology. It harvests bioplastics (PHA) granules, organic hydrolyzed protein, keratin fibers, bio-oils, protein-rich by products, and amino acids from bacteria. The company was incorporated in 2014 and is based in Lund, Sweden.
Technical Analysis
Scandinavian Enviro Systems AB
―
Axolot Solutions Holding AB
―
Nordic LEVEL Group AB Class B
―
CirChem AB
―
Clemondo Group AB
―